查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1768183

全球医疗保健人工智慧（AI）市场

Artificial Intelligence (AI) in Healthcare
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年，全球医疗保健人工智慧 (AI) 市场规模将达到 3,465 亿美元

2024年，全球医疗保健领域人工智慧 (AI) 市场规模估计为551亿美元，预计到2030年将达到3,465亿美元，2024年至2030年期间的复合年增长率为35.8%。软体是本报告分析的细分市场之一，预计其复合年增长率为37.1%，到分析期结束时将达到1772亿美元。硬体细分市场在分析期间内的复合年增长率估计为35.4%。

美国市场规模估计为 167 亿美元，中国市场预计复合年增长率为 34.1%

美国医疗保健领域的人工智慧 (AI) 市场规模预计在 2024 年达到 167 亿美元。预计到 2030 年，作为世界第二大经济体的中国市场规模将达到 498 亿美元，在 2024-2030 年的分析期内，复合年增长率将达到 34.1%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为 32.0% 和 30.1%。在欧洲，预计德国市场的复合年增长率约为 24.6%。

全球医疗保健市场人工智慧（AI）—主要趋势和驱动因素摘要

人工智慧如何提高诊断准确性和患者治疗效果？

人工智慧 (AI) 正在改变医疗保健领域的诊断方式，使其能够更快、更准确地进行评估，从而对患者的预后产生重大影响。传统上，诊断在很大程度上依赖临床医生的专业知识和经验，但现在，AI 透过快速分析医疗数据和影像来增强诊断过程，从而提高准确性并减少人为错误的可能性。例如，放射学中的机器学习演算法可以透过即时扫描影像资料来检测癌症、肺炎和心血管疾病等疾病的早期迹象，通常可以在症状出现之前就发现问题。 Zebra Medical Vision 和 Aidoc 等公司正在利用深度学习以惊人的准确性解读电脑断层扫描、MRI 和 X 光片，帮助放射科医生更快地做出明智的决策。此外，AI 模型透过分析电子健康记录(EHR)、检测结果和基因讯息，为医生提供切实可行的见解，以预测患者风险并追踪病情进展。透过实现更快的诊断和更个人化的治疗方案，AI主导的诊断技术正在改善患者预后、缩短住院时间，并为更积极主动的医疗保健方法铺平道路。

人工智慧可以改变个人化医疗和药物发现吗？

人工智慧在个人化治疗和加速药物研发方面的潜力正在重新定义全球产业分析师的患者照护方式。精准医疗是一个快速发展的领域，它利用人工智慧根据个人的基因组成、生活方式和特定健康状况量身定制治疗方案。透过分析包含遗传资讯、生活方式因素和既往健康记录的复杂数据集，人工智慧演算法可以提案高度个人化的治疗方案，以优化治疗效果并减少副作用。例如，IBM 的 Watson for Oncology 使用人工智慧根据个别患者数据和海量医学文献库提案癌症治疗方案，帮助肿瘤学家做出明智的决策。在药物研发领域，人工智慧可以加速潜在候选药物的识别，预测不同分子之间的相互作用，甚至识别可能的副作用，从而减少传统药物研发所需的时间和成本。 Atomwise 和 BenevolentAI 等人工智慧平台使用深度学习模型分析分子结构，从而加快了曾经耗时数年的研究过程。透过增强个人化医疗并加速药物研发，人工智慧正在彻底改变治疗方法的开发和交付方式，最终透过更有效、更及时的医疗保健解决方案使患者受益。

人工智慧如何帮助提高医疗保健领域的业务效率和资源管理？

人工智慧推动了医疗保健领域业务效率和资源管理的显着进步，解决了人员短缺、资源分配和患者等待时间等长期存在的问题。医院和医疗服务提供者正在利用人工智慧预测分析技术进行排班、人员编制和病患流量管理，以优化这些流程，消除过度拥挤并确保资源的有效利用。例如，演算法可以预测急诊和诊所的高峰时间，从而更好地准备和调整人员，从而最大限度地减少患者等待时间。此外，电子病历 (EHR) 管理中的人工智慧可以自动执行重复的管理业务，例如资料输入、索赔处理和开立发票，从而减轻了医护人员的管理负担并提高了整体效率。虚拟助理和聊天机器人进一步减轻了营运负担，例如回覆患者问询、安排预约和提醒患者服药，从而在不给医务人员带来压力的情况下提高了业务品质。透过简化业务，人工智慧使医疗服务提供者能够更加专注于直接的患者护理，提高效率并将资源分配到最需要的地方。

哪些因素将推动医疗保健领域人工智慧的发展？

医疗保健领域人工智慧市场的成长受到多种关键因素的推动，例如技术进步和不断发展的医疗保健需求加速了人工智慧的应用。医学影像、基因图谱和穿戴式医疗设备产生的医疗保健资料量不断增长，催生了对能够解读这些大量资料集的人工智慧主导分析的需求。消费者对个人化和主动性医疗保健服务的需求是主要驱动因素，因为患者越来越期望获得量身定制的治疗方案和预防性护理方案。自然语言处理和电脑视觉技术的进步增强了人工智慧解读医疗数据和基于语言的健康资讯的能力，使其成为诊断、病患监测和个人化医疗的关键。此外，全球正转向基于价值的医疗服务，这种医疗服务强调基于结果的治疗而非基于数量的服务，这与人工智慧在提高诊断准确性、优化治疗方案和预测患者结果方面的能力密切相关。慢性病的增加进一步增加了对患者监测和管理方面人工智慧解决方案的需求。政府措施和私人对医疗保健技术的投资正在加速该领域的研发，刺激创新并扩大人工智慧在医疗保健领域的应用。这是为了满足消费者的需求以及行业向数据驱动、高效和以患者为中心的护理的转变。

部分

组件（软体、硬体、服务）、技术（机器学习、自然语言处理、情境感知计算、电脑视觉）、应用（临床试验、机器人辅助手术、连网机器、诈骗侦测、诊断、虚拟助理、减少用药错误、其他应用）、最终用途（医院和医疗保健提供者、患者、製药和生物技术公司、医疗保健付款人、其他最终用途）

受访公司范例

  • Amazon Web Services（Aws）
  • Enlitic Inc.
  • General Electric Company
  • General Vision
  • Google
  • IBM Corporation
  • iCarbonX
  • Intel Corporation
  • Johnson & Johnson Services
  • Koninklijke Philips
  • Medtronic
  • Micron Technology
  • Microsoft Corporation
  • Next IT Corp.
  • Nvidia Corporation
  • Siemens Healthineers（A Strategic Unit Of Siemens Group）
  • Welltok Inc.

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 并未遵循典型的 LLM 或特定产业的 SLM查询，而是建立了一个从全球专家收集的内容库，其中包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 比赛

简介目录
Product Code: MCP21181

Global Artificial Intelligence (AI) in Healthcare Market to Reach US$346.5 Billion by 2030

The global market for Artificial Intelligence (AI) in Healthcare estimated at US$55.1 Billion in the year 2024, is expected to reach US$346.5 Billion by 2030, growing at a CAGR of 35.8% over the analysis period 2024-2030. Software, one of the segments analyzed in the report, is expected to record a 37.1% CAGR and reach US$177.2 Billion by the end of the analysis period. Growth in the Hardware segment is estimated at 35.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$16.7 Billion While China is Forecast to Grow at 34.1% CAGR

The Artificial Intelligence (AI) in Healthcare market in the U.S. is estimated at US$16.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$49.8 Billion by the year 2030 trailing a CAGR of 34.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 32.0% and 30.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 24.6% CAGR.

Global Artificial Intelligence (AI) in Healthcare Market - Key Trends and Drivers Summarized

How Is AI Enhancing Diagnostic Accuracy and Patient Outcomes?

Artificial Intelligence (AI) is transforming diagnostics in healthcare, enabling faster, more accurate assessments that significantly impact patient outcomes. Traditionally, diagnoses relied heavily on a clinician’s expertise and experience, but AI now augments this process by rapidly analyzing medical data and imaging with a level of precision that reduces the likelihood of human error. Machine learning algorithms in radiology, for example, can detect early signs of diseases like cancer, pneumonia, and cardiovascular disorders by scanning imaging data in real time, often identifying issues before symptoms manifest. Companies like Zebra Medical Vision and Aidoc are employing deep learning to interpret CT scans, MRIs, and X-rays with remarkable accuracy, assisting radiologists in making informed decisions quickly. Furthermore, AI models predict patient risks and track disease progression by analyzing electronic health records (EHRs), laboratory results, and genetic information, providing doctors with actionable insights. By enabling faster diagnoses and more personalized treatment plans, AI-driven diagnostics are improving patient outcomes, reducing hospital stays, and paving the way for a more proactive healthcare approach.

Can AI Transform Personalized Treatment and Drug Discovery?

AI’s potential to individualize treatments and expedite drug discovery is redefining how we approach patient care. Precision medicine, a rapidly growing field, leverages AI to customize treatment plans tailored to an individual’s unique genetic makeup, lifestyle, and specific health conditions. By analyzing complex datasets that include genetic information, lifestyle factors, and previous health records, AI algorithms can suggest highly personalized therapies, optimizing treatment efficacy and reducing adverse reactions. IBM’s Watson for Oncology, for instance, uses AI to recommend cancer treatment options based on individual patient data and an extensive library of medical literature, supporting oncologists in making well-informed decisions. In drug discovery, AI accelerates the identification of potential drug candidates, predicting how different molecules might interact and even identifying possible side effects, reducing the time and costs associated with traditional drug development. AI platforms like Atomwise and BenevolentAI use deep learning models to analyze molecular structures, expediting the research process that once took years. By enhancing personalized care and fast-tracking drug discovery, AI is revolutionizing how treatments are developed and delivered, ultimately benefiting patients through more effective and timely medical solutions.

How Is AI Assisting in Operational Efficiency and Resource Management in Healthcare?

AI is driving significant advancements in operational efficiency and resource management within the healthcare sector, addressing longstanding issues like staff shortages, resource allocation, and patient wait times. Hospitals and healthcare providers are utilizing AI-driven predictive analytics to manage scheduling, staff allocation, and patient flow, optimizing these processes to reduce overcrowding and ensure that resources are used efficiently. For example, algorithms can predict peak times in emergency departments or clinics, allowing for better preparation and staffing adjustments, thereby minimizing patient wait times. Additionally, AI in EHR management automates repetitive administrative tasks such as data entry, claims processing, and billing, reducing the administrative burden on healthcare staff and improving overall efficiency. Virtual health assistants and chatbots are further alleviating workload by addressing patient queries, scheduling appointments, and reminding patients of medication, enhancing service quality without overwhelming healthcare personnel. By streamlining operations, AI enables healthcare providers to focus more on direct patient care, increasing efficiency and ensuring resources are deployed where they are most needed.

What Factors Are Driving the Growth of AI in the Healthcare Market?

The growth in the AI in healthcare market is driven by several key factors, as advancements in technology and evolving healthcare needs accelerate AI adoption. Increasing healthcare data volumes, generated from medical imaging, genetic profiles, and wearable health devices, necessitate AI-driven analytics capable of making sense of these massive datasets. Consumer demand for personalized and proactive healthcare services is a primary driver, as patients increasingly expect tailored treatment plans and preventive care options. Technological advancements in natural language processing and computer vision are enhancing AI’s capabilities in interpreting medical data and language-based health information, making AI indispensable for diagnostics, patient monitoring, and personalized medicine. Additionally, the global shift toward value-based care, which emphasizes outcome-driven treatments over volume-based services, aligns closely with AI’s ability to improve diagnostic accuracy, optimize treatment plans, and predict patient outcomes. The rising prevalence of chronic diseases has further increased the need for AI solutions in patient monitoring and management. Government initiatives and private-sector investments in health technology are accelerating research and development in this area, encouraging innovation and expanding AI applications in healthcare. Together, these drivers indicate a transformative period for AI in healthcare, as it responds to both consumer demands and the industry’s shift towards data-centric, efficient, and patient-focused care.

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence (AI) in Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Software, Hardware, Services); Technology (Machine Learning, Natural Language Processing, Context-Aware Computing, Computer Vision); Application (Clinical Trials, Robot-Assisted Surgery, Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications); End-Use (Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 222 Featured) -

  • Amazon Web Services (Aws)
  • Enlitic Inc.
  • General Electric Company
  • General Vision
  • Google
  • IBM Corporation
  • iCarbonX
  • Intel Corporation
  • Johnson & Johnson Services
  • Koninklijke Philips
  • Medtronic
  • Micron Technology
  • Microsoft Corporation
  • Next IT Corp.
  • Nvidia Corporation
  • Siemens Healthineers (A Strategic Unit Of Siemens Group)
  • Welltok Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Artificial Intelligence (AI) in Healthcare - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Personalized Patient Care Propels Growth of AI in Healthcare
    • Focus on Early Disease Detection and Prevention Drives Adoption of AI-Powered Diagnostic Tools
    • Here's How Predictive Analytics in AI Enhances Patient Care Pathways and Outcome Optimization
    • Advances in Medical Imaging and Computer Vision Boost Precision in AI-Driven Diagnostic Solutions
    • Rising Prevalence of Chronic Diseases Expands Market for AI-Powered Remote Monitoring Systems
    • Here's How Natural Language Processing in AI Improves Medical Record Analysis and Documentation
    • Increasing Utilization of AI for Accelerating Drug Discovery and Development Processes
    • Focus on Enhancing Resource Allocation Drives AI Adoption in Healthcare Workforce Management
    • Growing Demand for Telemedicine Expands the Scope of AI in Remote Patient Monitoring
    • Here's How AI in Genomics Supports Personalized Treatment Plans and Precision Medicine Initiatives
    • Advancements in AI-Driven Robotics Transform Surgical and Rehabilitation Practices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Healthcare Payers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Healthcare Payers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals & Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for Hospitals & Healthcare Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Pharmaceuticals & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 16: World 6-Year Perspective for Pharmaceuticals & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Machine Learning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World 6-Year Perspective for Machine Learning by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Natural Language Processing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World 6-Year Perspective for Natural Language Processing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Context-Aware Computing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 22: World 6-Year Perspective for Context-Aware Computing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Computer Vision by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World 6-Year Perspective for Computer Vision by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 25: World Artificial Intelligence (AI) in Healthcare Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Connected Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Connected Machines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Fraud Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Fraud Detection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Virtual Assistants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: World 6-Year Perspective for Virtual Assistants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 36: World Recent Past, Current & Future Analysis for Dosage Error Reduction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 37: World 6-Year Perspective for Dosage Error Reduction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Clinical Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 41: World 6-Year Perspective for Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 42: World Recent Past, Current & Future Analysis for Robot-Assisted Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 43: World 6-Year Perspective for Robot-Assisted Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 46: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: USA 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 48: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: USA 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • CANADA
    • TABLE 52: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Canada 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 54: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Canada 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 58: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Canada 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 60: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 64: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Japan 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 66: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Japan 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 70: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: China 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 72: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: China 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 82: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 84: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 88: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: France 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 90: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: France 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 94: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Germany 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 96: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Germany 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 100: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Germany 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • ITALY
    • TABLE 102: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Italy 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 106: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Italy 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 108: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Italy 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 112: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: UK 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 114: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: UK 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 118: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 120: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 124: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 126: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Asia-Pacific 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 130: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Asia-Pacific 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 132: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Asia-Pacific 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 136: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Rest of World 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 138: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Rest of World 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030

IV. COMPETITION